Cargando…
Modulation of cerebral malaria by curcumin as an adjunctive therapy
Cerebral malaria is the most severe and rapidly fatal neurological complication of Plasmodium falciparum infection and responsible for more than two million deaths annually. The current therapy is inadequate in terms of reducing mortality or post-treatment symptoms such as neurological and cognitive...
Autores principales: | Jain, Kunal, Sood, Sumeet, Gowthamarajan, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425129/ https://www.ncbi.nlm.nih.gov/pubmed/23906771 http://dx.doi.org/10.1016/j.bjid.2013.03.004 |
Ejemplares similares
-
Olfactory drug delivery of artemether-curcumin combination for management of cerebral malaria
por: Jain, Kunal, et al.
Publicado: (2012) -
The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria
por: Mimche, Patrice N, et al.
Publicado: (2011) -
In vitro study of parasite elimination and endothelial protection by curcumin: adjunctive therapy for cerebral malaria
por: Kunwittaya, Sarun, et al.
Publicado: (2014) -
Pentoxifylline as an adjunct therapy in children with cerebral malaria
por: Lell, Bertrand, et al.
Publicado: (2010) -
The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
por: Serghides, Lena
Publicado: (2012)